MENU
CYCN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cyclerion Therapeutics (CYCN) Ownership - Who owns Cyclerion Therapeutics?
Profile
Industry
N/A
Address
245 First Street
Phone
+1 857 327-8778
Employees
1
Web
https://www.cyclerion.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.89M
P/E Ratio
N/A
Total Cash
2.87M
Projected Growth
N/A
Total Debt
N/A
Revenue
194K
Risk (Beta)
1.77
Dividend Yield
N/A
Total Cash/Share
1.06
Total Debt/Equity
N/A
Revenue/Share
0.08 USD as % of share price
Fundamentals
CYCN
Capitalization
8.89M
P/E Ratio
N/A
Risk (Beta)
1.77
Dividend Yield
N/A
Total Cash
2.87M
Total Cash/Share
1.06
Total Debt
0
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.08%
Revenue
194K
ROE
N/A
Book Value
8.2M
P/B Ratio
0.94
Cash Flow
N/A
Earnings
-2.13
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
0
Current Ratio
5.07
Current Revenue Per Employee
194000.00
Dividends Per Share - Security
N/A
EBITDA
-5.93M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-43.80
Shares Held By Institutions
3.42M
Shares Outstanding - Current
2.71M
Total Liabilities
700K
Total Volume MTD
N/A
Value
1
Gain YTD
-15.075
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products for serious and orphan diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
245 First Street
Phone
+1 857 327-8778
Employees
1
Web
https://www.cyclerion.com